Skip to main content
Erschienen in: Intensive Care Medicine 3/2012

01.03.2012 | Original

Early peak temperature and mortality in critically ill patients with or without infection

verfasst von: Paul Jeffrey Young, Manoj Saxena, Richard Beasley, Rinaldo Bellomo, Michael Bailey, David Pilcher, Simon Finfer, David Harrison, John Myburgh, Kathryn Rowan

Erschienen in: Intensive Care Medicine | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine whether fever is associated with an increased or decreased risk of death in patients admitted to an intensive care unit (ICU) with infection.

Methods

We evaluated the independent association between peak temperature in the first 24 h after ICU admission and in-hospital mortality according to whether there was an admission diagnosis of infection using a database of admissions to 129 ICUs in Australia and New Zealand (ANZ) (n = 269,078). Subsequently, we sought to confirm or refute the ANZ database findings using a validation cohort of admissions to 201 ICUs in the UK (n = 366,973).

Results

A total of 29,083/269,078 (10.8%) ANZ patients and 103,191/366,973 (28.1%) of UK patients were categorised as having an infection. In the ANZ cohort, adjusted in-hospital mortality risk progressively decreased with increasing peak temperature in patients with infection. Relative to the risk at 36.5–36.9°C, the lowest risk was at 39–39.4°C (adjusted OR 0.56; 95% CI 0.48–0.66). In patients without infection, the adjusted mortality risk progressively increased above 39.0°C (adjusted OR 2.07 at 40.0°C or above; 95% CI 1.68–2.55). In the UK cohort, findings were similar with adjusted odds ratios at corresponding temperatures of 0.77 (95% CI 0.71–0.85) and 1.94 (95% CI 1.60–2.34) for infection and non-infection groups, respectively.

Conclusions

Elevated peak temperature in the first 24 h in ICU is associated with decreased in-hospital mortality in critically ill patients with an infection; randomised trials are needed to determine whether controlling fever increases mortality in such patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Laupland KB, Shahpori R, Kirkpatrick AW, Ross T, Gregson DB, Stelfox HT (2008) Occurrence and outcome of fever in critically ill adults. Crit Care Med 36:1531–1535PubMedCrossRef Laupland KB, Shahpori R, Kirkpatrick AW, Ross T, Gregson DB, Stelfox HT (2008) Occurrence and outcome of fever in critically ill adults. Crit Care Med 36:1531–1535PubMedCrossRef
2.
Zurück zum Zitat Kluger MJ (1979) Fever: its biology, evolution and function. Princeton University Press, New Jersey, p 224 Kluger MJ (1979) Fever: its biology, evolution and function. Princeton University Press, New Jersey, p 224
3.
Zurück zum Zitat Mackowiak PA (1994) Fever: blessing or curse? A unifying hypothesis. Ann Intern Med 120:1037–1040PubMed Mackowiak PA (1994) Fever: blessing or curse? A unifying hypothesis. Ann Intern Med 120:1037–1040PubMed
4.
Zurück zum Zitat Bennett AE, Person JP, Simmons EE (1936) Treatment of chronic meningococcic infections in artificial fever. Arch Phys Ther 17:743–748 Bennett AE, Person JP, Simmons EE (1936) Treatment of chronic meningococcic infections in artificial fever. Arch Phys Ther 17:743–748
5.
Zurück zum Zitat Hench PS, Slocumb CH, Popp WC (1935) Fever therapy: results for gonorrheal arthritis, chronic infectious (atrophic) arthritis, and other forms of “rheumatism”. J Am Med Assoc 104:1779–1790CrossRef Hench PS, Slocumb CH, Popp WC (1935) Fever therapy: results for gonorrheal arthritis, chronic infectious (atrophic) arthritis, and other forms of “rheumatism”. J Am Med Assoc 104:1779–1790CrossRef
6.
Zurück zum Zitat Wagner-Jauregg J (1919) Uber die Einwirkung der Malaria auf die progressive Paralyse. Psychiat-Neurol Wchnschr 20:251–255 Wagner-Jauregg J (1919) Uber die Einwirkung der Malaria auf die progressive Paralyse. Psychiat-Neurol Wchnschr 20:251–255
7.
Zurück zum Zitat Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R (2010) The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med 103:403–411PubMedCrossRef Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R (2010) The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med 103:403–411PubMedCrossRef
9.
Zurück zum Zitat Doran T, de Angelis C, Baugardner R, Mellits E (1989) Acetaminophen: more harm than good for chickenpox? J Pediatr 114:1045–1048PubMedCrossRef Doran T, de Angelis C, Baugardner R, Mellits E (1989) Acetaminophen: more harm than good for chickenpox? J Pediatr 114:1045–1048PubMedCrossRef
10.
Zurück zum Zitat Brandts CH, Ndjave M, Graninger W, Kremsner PG (1997) Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 350:704–709PubMedCrossRef Brandts CH, Ndjave M, Graninger W, Kremsner PG (1997) Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 350:704–709PubMedCrossRef
11.
Zurück zum Zitat Stanley E, Jackson G, Panusarn C, Rubenis M, Dirda V (1975) Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 231:1248–1251PubMedCrossRef Stanley E, Jackson G, Panusarn C, Rubenis M, Dirda V (1975) Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 231:1248–1251PubMedCrossRef
12.
Zurück zum Zitat Horvath SM, Spurr GB, Hutt BK, Hamilton LH (1956) Metabolic cost of shivering. J Appl Physiol 8:595–602PubMed Horvath SM, Spurr GB, Hutt BK, Hamilton LH (1956) Metabolic cost of shivering. J Appl Physiol 8:595–602PubMed
13.
Zurück zum Zitat Greisman SE (1997) Cardiovascular alterations during fever. In: Mackowiak PA (ed) Fever: basic mechanisms and management, 2nd edn. Lippincott-Raven, Philadelphia, pp 143–165 Greisman SE (1997) Cardiovascular alterations during fever. In: Mackowiak PA (ed) Fever: basic mechanisms and management, 2nd edn. Lippincott-Raven, Philadelphia, pp 143–165
14.
Zurück zum Zitat Bruder N, Raynal M, Pellissier D, Courtinat C, Francois G (1998) Influence of body temperature, with and without sedation, on energy expenditure in severe head injuries. Crit Care Med 26:568–572PubMedCrossRef Bruder N, Raynal M, Pellissier D, Courtinat C, Francois G (1998) Influence of body temperature, with and without sedation, on energy expenditure in severe head injuries. Crit Care Med 26:568–572PubMedCrossRef
15.
Zurück zum Zitat Greer DM, Funk SE, Reaven NL, Ouzounelli M, Uman GC (2008) Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke 39:3029–3035PubMedCrossRef Greer DM, Funk SE, Reaven NL, Ouzounelli M, Uman GC (2008) Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke 39:3029–3035PubMedCrossRef
16.
Zurück zum Zitat Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K (2002) Treatment of comatose survivors of out of hospital cardiac arrest with induced hypothermia. N Engl J Med 346:557–563PubMedCrossRef Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K (2002) Treatment of comatose survivors of out of hospital cardiac arrest with induced hypothermia. N Engl J Med 346:557–563PubMedCrossRef
17.
Zurück zum Zitat Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ (2005) Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre, randomised trial. Lancet 365:663–670PubMed Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ (2005) Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre, randomised trial. Lancet 365:663–670PubMed
18.
Zurück zum Zitat Stow PJ, Hart GK, Higlett T, George C, Herkes R, McWilliam D, Bellomo R, for the ANZICS Database Management Committee (2006) Development and implementation of a high quality clinical database: the Australian and New Zealand Intensive Care Society Adult Patient Database. J Crit Care 21:133PubMedCrossRef Stow PJ, Hart GK, Higlett T, George C, Herkes R, McWilliam D, Bellomo R, for the ANZICS Database Management Committee (2006) Development and implementation of a high quality clinical database: the Australian and New Zealand Intensive Care Society Adult Patient Database. J Crit Care 21:133PubMedCrossRef
19.
Zurück zum Zitat Harrison DA, Brady AR, Rowan K (2005) Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit & Research Centre Case Mix Programme Database. Crit Care 9:S1–S13CrossRef Harrison DA, Brady AR, Rowan K (2005) Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit & Research Centre Case Mix Programme Database. Crit Care 9:S1–S13CrossRef
20.
Zurück zum Zitat Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A et al (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalised adults. Chest 100:1619–1636PubMedCrossRef Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A et al (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalised adults. Chest 100:1619–1636PubMedCrossRef
21.
Zurück zum Zitat Harrison DA, Parry GJ, Carpenter JR, Short A, Rowan K (2007) A new risk prediction model for critical care: the Intensive Care National Audit & Research Centre (ICNARC) model. Crit Care Med 35:1091–1098PubMedCrossRef Harrison DA, Parry GJ, Carpenter JR, Short A, Rowan K (2007) A new risk prediction model for critical care: the Intensive Care National Audit & Research Centre (ICNARC) model. Crit Care Med 35:1091–1098PubMedCrossRef
22.
Zurück zum Zitat Young JD, Goldfrad C, Rowan K, on behalf of the ICNARC Coding Method Working Group (2001) Development and testing of a hierarchical method to code the reason for admission to intensive care units: the ICNARC coding method. Brit J Anaesth 87:543–548PubMedCrossRef Young JD, Goldfrad C, Rowan K, on behalf of the ICNARC Coding Method Working Group (2001) Development and testing of a hierarchical method to code the reason for admission to intensive care units: the ICNARC coding method. Brit J Anaesth 87:543–548PubMedCrossRef
23.
Zurück zum Zitat Diringer MN, Reaven NL, Funk SE, Uman GC (2004) Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med 32:1489–1495PubMedCrossRef Diringer MN, Reaven NL, Funk SE, Uman GC (2004) Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med 32:1489–1495PubMedCrossRef
24.
Zurück zum Zitat Schulman CI, Namias N, Doherty J, Manning RJ, Li P, Elhaddad A, Lasko D, Amortegui J, Dy CJ, Dlugasch L, Baracco G, Cohn SM (2005) The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect (Larchmt) 6:369–375CrossRef Schulman CI, Namias N, Doherty J, Manning RJ, Li P, Elhaddad A, Lasko D, Amortegui J, Dy CJ, Dlugasch L, Baracco G, Cohn SM (2005) The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect (Larchmt) 6:369–375CrossRef
25.
Zurück zum Zitat Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 336:912–919PubMedCrossRef Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 336:912–919PubMedCrossRef
26.
Zurück zum Zitat Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB (1991) Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med 19:1339–1347PubMedCrossRef Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB (1991) Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med 19:1339–1347PubMedCrossRef
27.
Zurück zum Zitat Enders J, Shaffer M (1936) Studies on natural immunity to Pneumococcus type III: I. The capacity of strains of Pneumococcus type III to grow at 40°C and their virulence for rabbits. J Exp Med 64:7–18PubMedCrossRef Enders J, Shaffer M (1936) Studies on natural immunity to Pneumococcus type III: I. The capacity of strains of Pneumococcus type III to grow at 40°C and their virulence for rabbits. J Exp Med 64:7–18PubMedCrossRef
28.
Zurück zum Zitat Chu CM, Tian SF, Ren GF, Zhang YM, Zhang LX, Liu GQ (1982) Occurrence of temperature-sensitive influenza A viruses in nature. J Virol 41:353–359PubMed Chu CM, Tian SF, Ren GF, Zhang YM, Zhang LX, Liu GQ (1982) Occurrence of temperature-sensitive influenza A viruses in nature. J Virol 41:353–359PubMed
29.
Zurück zum Zitat Moench M (1926) A study of the heat sensitivity of the meningococcus in vitro within the range of therapeutic temperatures. J Lab Clin Med 57:665–676 Moench M (1926) A study of the heat sensitivity of the meningococcus in vitro within the range of therapeutic temperatures. J Lab Clin Med 57:665–676
30.
Zurück zum Zitat Mackowiak PA, Marling-Cason M, Cohen RL (1982) Effects of temperature on antimicrobial susceptibility of bacteria. J Infect Dis 145:550–553PubMedCrossRef Mackowiak PA, Marling-Cason M, Cohen RL (1982) Effects of temperature on antimicrobial susceptibility of bacteria. J Infect Dis 145:550–553PubMedCrossRef
31.
Zurück zum Zitat Arons MM, Wheeler AP, Bernard GR, Christman BW, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson W, Wright P, Dupont WD, Swindell BB (1999) Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Crit Care Med 27:699–707PubMedCrossRef Arons MM, Wheeler AP, Bernard GR, Christman BW, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson W, Wright P, Dupont WD, Swindell BB (1999) Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Crit Care Med 27:699–707PubMedCrossRef
32.
Zurück zum Zitat Frank SM, Fleisher LA, Breslow MJ, Higgins MS, Olson KF, Kelly S, Beattie C (1997) Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 277:1127–1134PubMedCrossRef Frank SM, Fleisher LA, Breslow MJ, Higgins MS, Olson KF, Kelly S, Beattie C (1997) Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 277:1127–1134PubMedCrossRef
33.
Zurück zum Zitat Kurz A, Sessler DI, Lenhardt R (1996) Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 334:1209–1215PubMedCrossRef Kurz A, Sessler DI, Lenhardt R (1996) Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 334:1209–1215PubMedCrossRef
Metadaten
Titel
Early peak temperature and mortality in critically ill patients with or without infection
verfasst von
Paul Jeffrey Young
Manoj Saxena
Richard Beasley
Rinaldo Bellomo
Michael Bailey
David Pilcher
Simon Finfer
David Harrison
John Myburgh
Kathryn Rowan
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 3/2012
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-012-2478-3

Weitere Artikel der Ausgabe 3/2012

Intensive Care Medicine 3/2012 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.